Spring 2012: RiverVest closes on four deals, exceeds industry benchmarks
RiverVest Venture Partners’ hands-on investment strategy netted big returns for its Fund I and II investors in 2011: the sale of two biopharmaceutical and two medical device companies, worth more than $1 billion.
